F T Cutts
Affiliation: London School of Hygiene and Tropical Medicine
- Measles elimination: progress, challenges and implications for rubella controlFelicity T Cutts
London School of Hygiene and Tropical Medicine Keppel St, London WC1E 7HT, UK
Expert Rev Vaccines 12:917-32. 2013..Countries and regions aiming to eliminate measles and control rubella urgently need to improve the implementation and monitoring of both routine and mass vaccination campaign strategies. ..
- Measuring coverage in MNCH: design, implementation, and interpretation challenges associated with tracking vaccination coverage using household surveysFelicity T Cutts
Independent Consultant, La Londe les Maures, France
PLoS Med 10:e1001404. 2013..To improve vaccination coverage estimates based on surveys, we recommend that recording tools and practices should be improved and that surveys should incorporate best practices for design, implementation, and analysis...
- Seasonality and outbreak of a predominant Streptococcus pneumoniae serotype 1 clone from The Gambia: expansion of ST217 hypervirulent clonal complex in West AfricaMartin Antonio
Bacterial Diseases Programme, Medical Research Council Laboratories, Banjul, The Gambia
BMC Microbiol 8:198. 2008..This study compares the molecular epidemiology of S. pneumoniae serotype 1 causing invasive disease in The Gambia between 1996 and 2005 to those carried in the nasopharynx between 2004 and 2006...
- Molecular epidemiology of pneumococci obtained from Gambian children aged 2-29 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccineMartin Antonio
Medical Research Council Laboratories, Banjul, The Gambia
BMC Infect Dis 8:81. 2008..The study describes the molecular epidemiology of Streptococcus pneumoniae causing invasive disease in Gambian children..
- Caution--mortality ratios aheadF T Cutts
Medical Research Council Laboratories, Banjul, Gambia
Lancet 361:2169-70. 2003
- Human papillomavirus and HPV vaccines: a reviewF T Cutts
Initiative for Vaccine Research, WHO, Geneva, Switzerland
Bull World Health Organ 85:719-26. 2007..Tiered pricing for HPV vaccines, innovative financing mechanisms and multidisciplinary partnerships will be essential in order for the vaccines to reach populations in greatest need...
- Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The GambiaM Saaka
Medical Research Council Laboratories, Fajara, Banjul, Gambia
Vaccine 26:3719-26. 2008..3 microg/ml (95% CI: 1.0, 5.0). The PCV-9 studied was immunogenic in a Gambian population where it was also found to be efficacious...
- Measles elimination: progress and challengesF T Cutts
Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK
Vaccine 17:S47-52. 1999....
- Modelling the incidence of congenital rubella syndrome in developing countriesF T Cutts
Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, UK
Int J Epidemiol 28:1176-84. 1999..Data on the burden of congenital rubella syndrome are important to guide rubella vaccination policies...
- Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trialF T Cutts
Medical Research Council Laboratories, Banjul, The Gambia
Lancet 365:1139-46. 2005..Pneumonia is estimated to cause 2 million deaths every year in children. Streptococcus pneumoniae is the most important cause of severe pneumonia. We aimed to assess the efficacy of a nine-valent pneumococcal conjugate vaccine in children...
- Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: Vaccination against rubellaS E Robertson
Global Programme for Vaccines and Immunization, World Health Organization, Geneva, Switzerland
Bull World Health Organ 75:69-80. 1997..Countries using rubella vaccine need to establish surveillance for rubella and CRS and monitor coverage in each of the target groups...
- Measles trends and vaccine effectiveness in Nairobi, KenyaP K Borus
Centre for Virus Research, Kenya Medical Research Institute, P O Box 54628, Nairobi, Kenya
East Afr Med J 80:361-4. 2003..To determine morbidity and mortality from measles and to estimate measles vaccine effectiveness among children hospitalised with measles in two hospitals in Nairobi...
- Serological and molecular epidemiology of measles virus outbreaks reported in Ethiopia during 2000-2004W Nigatu
Ethiopian Health and Nutrition Research Institute EHNRI, Addis Ababa, Ethiopia
J Med Virol 78:1648-55. 2006..Refinement of measles control measures might include targeting older age groups (5-14 years) and strengthening routine immunization particularly where importation of cases is a concern...
- Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine controlA Abebe
Virology and Rickettsiology Research Team, Ethiopian Health and Nutrition Research Institute EHNRI, Addis Ababa, PO Box 1242, Ethiopia
Epidemiol Infect 131:757-70. 2003..These results should target future research studies of underlying risk factors. Furthermore, we generate a crude estimate of the level of coverage of HBV vaccine that would be required to eliminate the virus from the study population...
- Seroepidemiology of measles in Addis Ababa, Ethiopia: implications for control through vaccinationF Enquselassie
Department of Community Health, Faculty of Medicine, University of Addis Ababa, PO Box 1176, Addis Ababa, Ethiopia
Epidemiol Infect 130:507-19. 2003..Our data support the introduction of campaign vaccination in the city in 1998, although higher routine vaccine coverage is required to sustain the impact. The implications of a high prevalence of low-level antibody are discussed...
- Measles virus strains circulating in Ethiopia in 1998-1999: molecular characterisation using oral fluid samples and identification of a new genotypeW Nigatu
Ethiopian Health and Nutrition Research Institute, Addis Ababa, Ethiopia
J Med Virol 65:373-80. 2001..The degree of divergence from recognised clade D strains suggested that, together with three strains from the United Kingdom, it represents an additional genotype of clade D (GenBank accession numbers AF280800-280807)...
- Measles control in Maputo, Mozambique, using a single dose of Schwarz vaccine at age 9 monthsF T Cutts
Communicable Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, England
Bull World Health Organ 72:227-31. 1994..The proportion of cases in children aged > or = 5 years increased from 15.2% to 32.8% in the corresponding periods. The global goals for measles control can be achieved by a single dose of Schwarz vaccine at 9 months of age...
- Principles of measles controlF T Cutts
Immunization Division, Centers for Disease Control, Atlanta, GA 30333
Bull World Health Organ 69:1-7. 1991....